Clinical Trial

Islet Transplantation in Type 1 Diabetic Kidney Allograft

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn about the safety of islet transplantation when performed after kidney transplantation, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. These cells will be obtained from cadaver (non-living) donors and given to subjects by vein.
Protocol Amendment History 21 amendments
This ClinicalTrials.gov record has been amended 21 times since 2010-11-15; most recent amendment 2025-12-02.
Status change: Active, Not Recruiting → Recruiting 2019-04-18
Status change: Recruiting → Active, Not Recruiting 2017-06-08
Status change: Not Yet Recruiting → Recruiting 2011-04-25
Trial Details
NCT Number NCT01241864
Lead Sponsor University of Chicago
Conditions Diabetes Mellitus, Type 1
Enrollment 10 participants
Start Date 2010-12
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-08